Extemporaneous combination therapy with nebivolol/amlodipine for the treatment of hypertension: a real-world evidence study in Europe

References

• Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980.
   PubMed Web of Science ®Google Scholar
• Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;41:1874–2071.
   PubMedGoogle Scholar
• Vaduganathan M, Mensah GA, Turco JV, et al. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–2371. doi: 10.1016/j.jacc.2022.11.005.
   PubMed Web of Science ®Google Scholar
• Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71(6):1269–1324. doi: 10.1161/HYP.0000000000000066.
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913. doi: 10.1016/s0140-6736(02)11911-8.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Thomopoulos C. Combination drug treatment in hypertension. Pharmacol Res. 2017;125(Pt B):266–271. doi: 10.1016/j.phrs.2017.09.011.
   PubMed Web of Science ®Google Scholar
• Gradman AH, Basile JN, Carter BL, et al. Combination therapy in hypertension. J Clin Hypertens (Greenwich). 2011;13(3):146–154. doi: 10.1111/j.1751-7176.2010.00397.x.
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290–300. doi: 10.1016/j.amjmed.2008.09.038.
   PubMed Web of Science ®Google Scholar
• Schutte AE, Jafar TH, Poulter NR, et al. Addressing global disparities in blood pressure control: perspectives of the international society of hypertension. Cardiovasc Res. 2023;119(2):381–409. doi: 10.1093/cvr/cvac130.
   PubMed Web of Science ®Google Scholar
• Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–618. doi: 10.1097/HJH.0b013e328342ca97.
   PubMed Web of Science ®Google Scholar
• Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125(9):882–887 e1. doi: 10.1016/j.amjmed.2011.12.013.
   PubMed Web of Science ®Google Scholar
• Jung O, Gechter JL, Wunder C, et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766–774. doi: 10.1097/HJH.0b013e32835e2286.
   PubMed Web of Science ®Google Scholar
• Tomaszewski M, White C, Patel P, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart. 2014;100(11):855–861. doi: 10.1136/heartjnl-2013-305063.
   PubMed Web of Science ®Google Scholar
• Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215–225. doi: 10.1093/eurheartj/ehi115.
   PubMed Web of Science ®Google Scholar
• Fongemie J, Felix-Getzik E. A review of nebivolol pharmacology and clinical evidence. Drugs. 2015;75(12):1349–1371. doi: 10.1007/s40265-015-0435-5.
   PubMed Web of Science ®Google Scholar
• Mason RP, Giles TD, Sowers JR. Evolving mechanisms of action of beta blockers: focus on nebivolol. J Cardiovasc Pharmacol. 2009;54(2):123–128. doi: 10.1097/FJC.0b013e3181ad207b.
   PubMed Web of Science ®Google Scholar
• Ferri C. The role of nebivolol in the management of hypertensive patients: from pharmacological profile to treatment guidelines. Future Cardiol. 2021;17(8):1421–1433. doi: 10.2217/fca-2021-0048.
   PubMed Web of Science ®Google Scholar
• Fares H, DiNicolantonio JJ, O'Keefe JH, et al. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016;3(2):e000473. doi: 10.1136/openhrt-2016-000473.
   PubMed Web of Science ®Google Scholar
• Cohen BJ. A fixed-dose combination of bisoprolol and amlodipine for hypertension: a potential benefit to selected patients. Clin Pharmacol Drug Dev. 2017;6(1):6–8. doi: 10.1002/cpdd.325.
   PubMed Web of Science ®Google Scholar
• Sever PS, Messerli FH. Hypertension management 2011: optimal combination therapy. Eur Heart J. 2011;32(20):2499–2506. doi: 10.1093/eurheartj/ehr177.
   PubMed Web of Science ®Google Scholar
• Volpe M, Pegoraro V, Peduto I, et al. Extemporaneous combination therapy with nebivolol/zofenopril in hypertensive patients: usage in Italy. Curr Med Res Opin. 2022;38(10):1673–1681. doi: 10.1080/03007995.2022.2096352.
   PubMed Web of Science ®Google Scholar
• Volpe M, Pegoraro V, Heiman F, et al. Extemporaneous combination therapy with amlodipine/zofenopril in hypertensive patients: a real-world data analysis in Italy. Curr Med Res Opin. 2023;39(12):1593–1601. doi: 10.1080/03007995.2023.2192607.
   PubMed Web of Science ®Google Scholar
• Bergmann KC, Skowasch D, Timmermann H, et al. Prevalence of patients with uncontrolled asthma Despite NVL/GINA step 4/5 treatment in Germany. J Asthma Allergy. 2022;15:897–906. doi: 10.2147/JAA.S365967.
   PubMed Web of Science ®Google Scholar
• Joumaa H, Sigogne R, Maravic M, et al. Artificial intelligence to differentiate asthma from COPD in medico-administrative databases. BMC Pulm Med. 2022;22(1):357. doi: 10.1186/s12890-022-02144-2.
   PubMed Web of Science ®Google Scholar
• Rathmann W, Czech M, Franek E, et al. Regional differences in insulin therapy regimens in five european countries. Int J Clin Pharmacol Ther. 2017;55(5):403–408. doi: 10.5414/CP202906.
   PubMed Web of Science ®Google Scholar
• Bekele BB, Harsha N, Kőrösi L, et al. Is prescription nonredemption a source of poor health Among the roma? Cross-sectional analysis of drug consumption data From the national health insurance fund of Hungary. Front Pharmacol. 2021;12:616092. doi: 10.3389/fphar.2021.616092.
   PubMed Web of Science ®Google Scholar
• IQVIA. Osservatorio sull’impatto della pandemia COVID-19 sull’accesso alle cure. Periodo dati: 2019-2020 2021. [cited 2022 24 October]. Available from: https://www.farmindustria.it/app/uploads/2021/03/Osservatorio-IQVIA-sullimpatto-pandemia-sullaccesso-alle-cure_Marzo-2021.pdf.
   Google Scholar
• SIIA. SIdIA. Ipertensione: i numeri in Italia 2023. [cited 2023 31 May]. Available from: https://siia.it/per-il-pubblico/ipertensione/ipertensione-i-numeri-in-italia/.
   Google Scholar
• ISTAT., Statistica INd. Popolazione residente al 1° gennaio 2023. 2023. [cited 2023 31 May]. Available from: http://dati.istat.it/Index.aspx?QueryId=42869.
   Google Scholar
• STATIS. DotFSOoGD. Popolazione residente al 1° gennaio 2023. 2023. [cited 2023 31 May]. Available from: https://www-genesis.destatis.de/genesis/online?operation=sprachwechsel&language=en.
   Google Scholar
• Levi M, Pasqua A, Cricelli I, et al. Patient adherence to olmesartan/amlodipine combinations: fixed Versus extemporaneous combinations. J Manag Care Spec Pharm. 2016;22(3):255–262. doi: 10.18553/jmcp.2016.22.3.255.
   PubMedGoogle Scholar
• Yang W, Chang J, Kahler KH, et al. Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Curr Med Res Opin. 2010;26(9):2065–2076. doi: 10.1185/03007995.2010.494462.
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–1605. doi: 10.1161/CIRCULATIONAHA.108.830299.
   PubMed Web of Science ®Google Scholar
• Del Pinto R, Desideri G, Ferri C, et al. Real-world antihypertensive treatment patterns, treatment adherence, and blood pressure control in the elderly: an Italian awareness-raising campaign on hypertension by senior Italia FederAnziani, the Italian Society of Hypertension and the Italian Federation of General Practitioners. High Blood Press Cardiovasc Prev. 2021;28(5):457–466. doi: 10.1007/s40292-021-00465-7.
   PubMed Web of Science ®Google Scholar
• Deng Y, Bai J, Yang X, et al. Achieved systolic blood pressure and cardiovascular outcomes in 60-80-year-old patients: the strategy of blood pressure intervention in the elderly hypertensive patients (STEP) trial. Eur J Prev Cardiol. 2023;30(10):1017–1027. doi: 10.1093/eurjpc/zwad142.
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM, Chase JA, et al. Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr Hypertens Rep. 2015;17(12):94. doi: 10.1007/s11906-015-0606-5.
   PubMed Web of Science ®Google Scholar
• Rao S, Jamal Siddiqi T, Khan MS, et al. Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: a systematic review and meta-analysis of randomized controlled trials. Prog Cardiovasc Dis. 2022;73:48–55. Jul- doi: 10.1016/j.pcad.2022.01.005.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Joseph P, Dans A, et al. Polypill with or without aspirin in persons without cardiovascular disease. N Engl J Med. 2021;384(3):216–228. doi: 10.1056/NEJMoa2028220.
   PubMed Web of Science ®Google Scholar
• Baumgartner A, Drame K, Geutjens S, et al. Does the polypill improve patient adherence compared to its individual formulations? A systematic review. Pharmaceutics. 2020;12(2):190. doi: 10.3390/pharmaceutics12020190.
   PubMed Web of Science ®Google Scholar
• AIFA. National Report on Medicines Use in Italy. Year 2021. 2022 [cited 2023 31 May]. Available from: https://www.aifa.gov.it/documents/20142/1740782/Rapporto-OsMed-2021_EN.pdf.
   Google Scholar
• International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2019. [cited 2023 18 July]. Available from: https://icd.who.int/browse10/2019/en.
   Google Scholar
• Gottwald-Hostalek U, Sun N, Barho C, et al. Management of hypertension with a fixed-dose (single-Pill) combination of bisoprolol and amlodipine. Clin Pharmacol Drug Dev. 2017;6(1):9–18. doi: 10.1002/cpdd.309.
   PubMed Web of Science ®Google Scholar
• Mazza A, Gil-Extremera B, Maldonato A, et al. Nebivolol vs amlodipine as first-line treatment of essential arterial hypertension in the elderly. Blood Press. 2002;11(3):182–188. doi: 10.1080/080370502760050421.
   PubMed Web of Science ®Google Scholar
• Sultan EM, Rabea H, Elberry AA, et al. Effect of amlodipine/nebivolol combination therapy on Central BP and PWV compared to amlodipine/valsartan combination therapy. Egypt Heart J. 2022;74(1):15. doi: 10.1186/s43044-022-00254-0.
   PubMedGoogle Scholar
• Cicero AFG, Kuwabara M, Borghi C. A critical review of nebivolol and its fixed-dose combinations in the treatment of hypertension. Drugs. 2018;78(17):1783–1790. doi: 10.1007/s40265-018-0999-y.
   PubMed Web of Science ®Google Scholar
• EUDRACT. [cited 2023 18 July]. Available from: https://www.clinicaltrialsregister.eu/ctr-search/search?query=2021-005077-10.
   Google Scholar
• Trimarco V, Izzo R, Mone P, et al. Therapeutic concordance improves blood pressure control in patients with resistant hypertension. Pharmacol Res. 2023;187:106557. doi: 10.1016/j.phrs.2022.106557.
   PubMed Web of Science ®Google Scholar